Alignment Healthcare (ALHC) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

ALHC Stock Forecast

Alignment Healthcare stock forecast is as follows: an average price target of $10.00 (represents a -5.75% downside from ALHC’s last price of $10.61) and a rating consensus of 'Buy', based on 13 wall street analysts offering a 1-year stock forecast.

ALHC Price Target

The average price target for Alignment Healthcare (ALHC) is $10.00 based on 1-year price targets from 13 Wall Street analysts in the past 3 months, with a price target range of $12.00 to $7.00. This represents a potential -5.75% downside from ALHC's last price of $10.61.

ALHC Analyst Ratings

Buy

According to 13 Wall Street analysts, Alignment Healthcare's rating consensus is 'Buy'. The analyst rating breakdown for ALHC stock is 1 'Strong Buy' (7.69%), 7 'Buy' (53.85%), 4 'Hold' (30.77%), 1 'Sell' (7.69%), and 0 'Strong Sell' (0.00%).

Alignment Healthcare Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Aug 14, 2024	Michael Ha	Robert W. Baird	$11.00	$8.49	29.56%	3.68%
Aug 05, 2024	Andrew Mok	Barclays	$7.00	$8.94	-21.70%	-34.02%
Jul 26, 2024	Craig Jones	Stifel Nicolaus	$12.00	$9.36	28.21%	13.10%
May 08, 2024	Jessica Tassan	Piper Sandler	$8.00	$6.78	17.99%	-24.60%
Oct 16, 2023	John Ransom	Raymond James	$10.00	$6.62	51.06%	-5.75%
Oct 12, 2023	Scott Fidel	Stephens	$9.00	$6.29	43.20%	-15.17%

The latest Alignment Healthcare stock forecast, released on Aug 14, 2024 by Michael Ha from Robert W. Baird, set a price target of $11.00, which represents a 29.56% increase from the stock price at the time of the forecast ($8.49), and a 3.68% increase from ALHC last price ($10.61).

Alignment Healthcare Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	4
Avg Price Target	-	-	$9.50
Last Closing Price	$10.61	$10.61	$10.61
Upside/Downside	-100.00%	-100.00%	-10.46%

In the current month, the average price target of Alignment Healthcare stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Alignment Healthcare's last price of $10.61. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Oct 31, 2024	Cowen & Co.	Buy	Buy	Hold
Oct 30, 2024	Barclays	Underweight	Underweight	Hold
Oct 10, 2024	KeyBanc		Sector Weight	Initialise
Aug 06, 2024	Piper Sandler	Overweight	Overweight	Hold
Aug 06, 2024	Cowen & Co.	Buy	Buy	Hold
Aug 05, 2024	Barclays	Underweight	Underweight	Hold
May 03, 2024	Stephens	Equal-Weight	Equal-Weight	Hold
Oct 16, 2023	Raymond James	Outperform	Strong Buy	Upgrade
Oct 12, 2023	UBS		Buy	Initialise
Oct 12, 2023	Stephens		Equal-Weight	Initialise
Oct 12, 2023	Seaport Global		Buy	Initialise
Oct 12, 2023	Citigroup		Neutral	Initialise
Oct 12, 2023	Cantor Fitzgerald		Overweight	Initialise
Oct 12, 2023	BMO Capital		Outperform	Initialise
Oct 12, 2023	Needham		Hold	Initialise
May 01, 2023	Raymond James		Outperform	Upgrade
May 26, 2022	Bank of America Securities		Buy	Upgrade
Feb 24, 2022	Piper Sandler	Overweight	Overweight	Hold

Alignment Healthcare's last stock rating was published by Cowen & Co. on Oct 31, 2024. The company gave ALHC a "Buy" rating, the same as its previous rate.

Alignment Healthcare Financial Forecast

Alignment Healthcare Revenue Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	$465.39M	$456.71M	$462.38M	$439.15M	$361.81M	$360.35M	$366.47M	$345.53M	$298.27M	$293.47M	$308.95M	$267.08M
Avg Forecast	$1.05B	$1.08B	$1.10B	$1.05B	$855.35M	$875.26M	$884.49M	$853.47M	$674.97M	$669.79M	$637.66M	$599.75M	$444.56M	$443.45M	$438.97M	$431.34M	$341.10M	$333.40M	$336.97M	$332.48M	$269.57M	$275.48M	$267.35M	$250.91M
High Forecast	$1.10B	$1.14B	$1.15B	$1.11B	$900.79M	$921.76M	$931.49M	$886.65M	$690.86M	$677.34M	$637.66M	$600.90M	$462.23M	$443.45M	$462.29M	$454.26M	$359.22M	$333.40M	$336.97M	$332.48M	$269.57M	$275.48M	$267.35M	$250.91M
Low Forecast	$1.01B	$1.04B	$1.05B	$1.01B	$821.87M	$841.01M	$849.88M	$821.79M	$666.72M	$662.24M	$637.66M	$598.61M	$435.24M	$443.45M	$421.79M	$414.46M	$327.75M	$333.40M	$336.97M	$332.48M	$269.57M	$275.48M	$267.35M	$250.91M
# Analysts	3	3	3	3	4	4	4	6	8	4	5	4	8	4	5	4	4	3	4	3	5	4	5	4
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	1.05%	1.03%	1.05%	1.02%	1.06%	1.08%	1.09%	1.04%	1.11%	1.07%	1.16%	1.06%

Alignment Healthcare's average Quarter revenue forecast for Mar 24 based on 4 analysts is $599.75M, with a low forecast of $598.61M, and a high forecast of $600.90M. ALHC's average Quarter revenue forecast represents a 28.87% increase compared to the company's last Quarter revenue of $465.39M (Dec 23).

Alignment Healthcare EBITDA Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21
# Analysts	3	3	3	3	4	4	4	6	8	4	5	4	8	4	5	4	4	3	4	3	5	4	5	4
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	$-35.95M	$-24.11M	$-18.02M	$-27.37M	$-47.34M	$-28.77M	$-2.86M	$-32.42M	$-43.25M	$-37.27M	$-36.47M	$-48.84M
Avg Forecast	$-59.26M	$-61.12M	$-62.08M	$-59.42M	$-48.43M	$-49.56M	$-50.08M	$-48.32M	$-38.22M	$-37.92M	$-36.10M	$-33.96M	$-25.17M	$-25.11M	$-24.85M	$-24.42M	$-19.31M	$-18.77M	$-18.98M	$-35.02M	$-15.18M	$-15.51M	$-15.06M	$-42.13M
High Forecast	$-56.94M	$-58.72M	$-59.65M	$-57.09M	$-46.53M	$-47.62M	$-48.12M	$-46.53M	$-37.75M	$-37.50M	$-36.10M	$-33.89M	$-24.64M	$-25.11M	$-23.88M	$-23.47M	$-18.56M	$-18.77M	$-18.98M	$-28.01M	$-15.18M	$-15.51M	$-15.06M	$-33.71M
Low Forecast	$-62.41M	$-64.36M	$-65.38M	$-62.58M	$-51.00M	$-52.19M	$-52.74M	$-50.20M	$-39.12M	$-38.35M	$-36.10M	$-34.02M	$-26.17M	$-25.11M	$-26.18M	$-25.72M	$-20.34M	$-18.77M	$-18.98M	$-42.02M	$-15.18M	$-15.51M	$-15.06M	$-50.56M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	1.43%	0.96%	0.72%	1.12%	2.45%	1.53%	0.15%	0.93%	2.85%	2.40%	2.42%	1.16%

undefined analysts predict ALHC's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Alignment Healthcare's previous annual EBITDA (undefined) of $NaN.

Alignment Healthcare Net Income Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21
# Analysts	3	3	3	3	4	4	4	6	8	4	5	4	8	4	5	4	4	3	4	3	5	4	5	4
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	$-47.21M	$-35.05M	$-28.48M	$-37.37M	$-56.99M	$-40.25M	$-16.51M	$-45.16M	$-52.29M	$-45.82M	$-44.76M	$-56.87M
Avg Forecast	$-25.83M	$-9.13M	$-7.46M	$-38.52M	$-32.66M	$-16.39M	$-14.46M	$-40.94M	$-36.66M	$-26.57M	$-27.31M	$-43.53M	$-43.36M	$-35.11M	$-35.01M	$-48.85M	$-56.83M	$-46.46M	$-49.11M	$-44.08M	$-52.84M	$-31.25M	$-20.09M	$-49.07M
High Forecast	$-24.52M	$-8.67M	$-7.08M	$-36.56M	$-30.99M	$-15.55M	$-13.73M	$-38.89M	$-26.48M	$-25.22M	$-25.92M	$-41.31M	$-37.45M	$-33.32M	$-33.23M	$-46.36M	$-53.94M	$-46.46M	$-49.11M	$-35.27M	$-52.84M	$-31.25M	$-20.09M	$-39.25M
Low Forecast	$-27.62M	$-9.76M	$-7.98M	$-41.18M	$-34.91M	$-17.52M	$-15.46M	$-45.03M	$-42.77M	$-28.41M	$-29.20M	$-46.53M	$-49.27M	$-37.53M	$-37.43M	$-52.22M	$-60.75M	$-46.46M	$-49.11M	$-52.90M	$-52.84M	$-31.25M	$-20.09M	$-58.88M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	1.09%	1.00%	0.81%	0.77%	1.00%	0.87%	0.34%	1.02%	0.99%	1.47%	2.23%	1.16%

Alignment Healthcare's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. ALHC's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Alignment Healthcare SG&A Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21
# Analysts	3	3	3	3	4	4	4	6	8	4	5	4	8	4	5	4	4	3	4	3	5	4	5	4
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	$83.74M	$83.09M	$70.20M	$70.41M	$83.23M	$76.45M	$61.67M	$74.29M	$78.08M	$76.85M	$71.15M	$64.91M
Avg Forecast	$195.18M	$201.30M	$204.49M	$195.71M	$159.51M	$163.23M	$164.95M	$159.16M	$125.88M	$124.91M	$118.92M	$111.85M	$82.91M	$82.70M	$81.86M	$80.44M	$63.61M	$62.18M	$62.84M	$80.24M	$50.27M	$51.38M	$49.86M	$56.00M
High Forecast	$205.55M	$211.99M	$215.35M	$206.11M	$167.99M	$171.90M	$173.71M	$165.35M	$128.84M	$126.32M	$118.92M	$112.06M	$86.20M	$82.70M	$86.21M	$84.71M	$66.99M	$62.18M	$62.84M	$96.28M	$50.27M	$51.38M	$49.86M	$67.20M
Low Forecast	$187.54M	$193.42M	$196.48M	$188.05M	$153.27M	$156.84M	$158.49M	$153.26M	$124.34M	$123.50M	$118.92M	$111.63M	$81.17M	$82.70M	$78.66M	$77.29M	$61.12M	$62.18M	$62.84M	$64.19M	$50.27M	$51.38M	$49.86M	$44.80M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	1.01%	1.00%	0.86%	0.88%	1.31%	1.23%	0.98%	0.93%	1.55%	1.50%	1.43%	1.16%

Alignment Healthcare's average Quarter SG&A projection for Mar 24 is $111.85M, based on 4 Wall Street analysts, with a range of $111.63M to $112.06M. The forecast indicates a 33.57% rise compared to ALHC last annual SG&A of $83.74M (Dec 23).

Alignment Healthcare EPS Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21
# Analysts	3	3	3	3	4	4	4	6	8	4	5	4	8	4	5	4	4	3	4	3	5	4	5	4
EPS	-	-	-	-	-	-	-	-	-	-	-	-	$-0.25	$-0.19	$-0.15	$-0.20	$-0.31	$-0.22	$-0.09	$-0.25	$-0.29	$-0.26	$-0.25	$-0.37
Avg Forecast	$-0.13	$-0.05	$-0.04	$-0.20	$-0.17	$-0.09	$-0.08	$-0.21	$-0.19	$-0.14	$-0.14	$-0.23	$-0.23	$-0.18	$-0.18	$-0.26	$-0.30	$-0.24	$-0.26	$-0.23	$-0.28	$-0.16	$-0.11	$-0.19
High Forecast	$-0.13	$-0.05	$-0.04	$-0.19	$-0.16	$-0.08	$-0.07	$-0.20	$-0.14	$-0.13	$-0.14	$-0.22	$-0.20	$-0.17	$-0.17	$-0.24	$-0.28	$-0.24	$-0.26	$-0.23	$-0.28	$-0.16	$-0.11	$-0.19
Low Forecast	$-0.14	$-0.05	$-0.04	$-0.22	$-0.18	$-0.09	$-0.08	$-0.24	$-0.22	$-0.15	$-0.15	$-0.24	$-0.26	$-0.20	$-0.20	$-0.27	$-0.32	$-0.24	$-0.26	$-0.23	$-0.28	$-0.16	$-0.11	$-0.19
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	1.10%	1.04%	0.82%	0.78%	1.04%	0.90%	0.35%	1.09%	1.05%	1.59%	2.38%	1.97%

According to undefined Wall Street analysts, Alignment Healthcare's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to ALHC previous annual EPS of $NaN (undefined).

Alignment Healthcare Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
OSCR	Oscar Health	$13.50	$28.00	107.41%	Buy
CVS	CVS Health	$44.04	$73.50	66.89%	Buy
CI	Cigna	$265.59	$400.00	50.61%	Buy
ELV	Elevance Health	$366.30	$542.14	48.00%	Buy
CNC	Centene	$57.81	$81.50	40.98%	Buy
CLOV	Clover Health Investments	$3.21	$4.25	32.40%	Hold
UNH	UnitedHealth Group	$485.52	$618.75	27.44%	Buy
HUM	Humana	$233.89	$292.13	24.90%	Hold
MOH	Molina Healthcare	$291.78	$347.00	18.93%	Hold
ALHC	Alignment Healthcare	$10.83	$10.00	-7.66%	Buy

ALHC Forecast FAQ

Is Alignment Healthcare a good buy?

Yes, according to 13 Wall Street analysts, Alignment Healthcare (ALHC) is considered a 'Buy'. The rating consensus is based on 1 'Strong Buy' and 7 'Buy' recommendations, accounting for 61.54% of ALHC's total ratings.

What is ALHC's price target?

Alignment Healthcare (ALHC) average price target is $10 with a range of $7 to $12, implying a -5.75% from its last price of $10.61. The data is based on 13 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Alignment Healthcare stock go up soon?

According to Wall Street analysts' prediction for ALHC stock, the company can go down by -5.75% (from the last price of $10.61 to the average price target of $10), up by 13.10% based on the highest stock price target, and down by -34.02% based on the lowest stock price target.

Can Alignment Healthcare stock reach $20?

ALHC's average twelve months analyst stock price target of $10 does not support the claim that Alignment Healthcare can reach $20 in the near future.

What are Alignment Healthcare's analysts' financial forecasts?

Alignment Healthcare's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $3.47B (high $3.64B, low $3.33B), average EBITDA is $-196M (high $-189M, low $-206M), average net income is $-104M (high $-99.165M, low $-113M), average SG&A $646.86M (high $678.96M, low $621.86M), and average EPS is $-0.546 (high $-0.518, low $-0.59). ALHC's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $4.27B (high $4.5B, low $4.1B), average EBITDA is $-242M (high $-232M, low $-255M), average net income is $-80.948M (high $-76.83M, low $-86.538M), average SG&A $796.68M (high $839.01M, low $765.5M), and average EPS is $-0.423 (high $-0.401, low $-0.452).

Did the ALHC's actual financial results beat the analysts' financial forecasts?

Based on Alignment Healthcare's last annual report (Dec 2023), the company's revenue was $1.82B, beating the average analysts forecast of $1.76B by 3.71%. Apple's EBITDA was $-105M, beating the average prediction of $-99.556M by 5.86%. The company's net income was $-148M, missing the average estimation of $-162M by -8.81%. Apple's SG&A was $307.43M, missing the average forecast of $327.91M by -6.25%. Lastly, the company's EPS was $-0.79, missing the average prediction of $-0.848 by -6.87%. In terms of the last quarterly report (Dec 2023), Alignment Healthcare's revenue was $465.39M, beating the average analysts' forecast of $444.56M by 4.69%. The company's EBITDA was $-35.948M, beating the average prediction of $-25.171M by 42.82%. Alignment Healthcare's net income was $-47.209M, beating the average estimation of $-43.359M by 8.88%. The company's SG&A was $83.74M, beating the average forecast of $82.91M by 1.00%. Lastly, the company's EPS was $-0.25, beating the average prediction of $-0.227 by 10.34%